| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,842 |
12,474 |
$1.49M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,045 |
8,889 |
$832K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
7,791 |
6,366 |
$777K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,339 |
4,961 |
$487K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,062 |
10,357 |
$402K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,192 |
3,883 |
$84K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,480 |
4,167 |
$47K |
| 99215 |
Prolong outpt/office vis |
161 |
155 |
$22K |
| 87428 |
|
2,938 |
1,095 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
355 |
199 |
$13K |
| 87400 |
|
857 |
615 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
320 |
162 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
120 |
119 |
$4K |
| 99205 |
Prolong outpt/office vis |
26 |
26 |
$4K |
| 81025 |
|
664 |
623 |
$3K |
| 81003 |
|
1,598 |
1,429 |
$2K |
| 96127 |
|
710 |
652 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
141 |
131 |
$1K |
| S9083 |
Global fee urgent care centers |
15 |
15 |
$533.80 |
| 93000 |
|
42 |
40 |
$356.20 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$239.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
28 |
$214.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
13 |
$0.72 |
| 3351F |
|
750 |
670 |
$0.01 |
| 3353F |
|
37 |
35 |
$0.00 |
| 3352F |
|
89 |
84 |
$0.00 |